High Resolution Melting Analysis is Very Useful to Identify Breast Cancer Type 1 Susceptibility Protein (BRCA1) c.4964_4982del19 (rs80359876) Founder Calabrian Pathogenic Variant on Peripheral Blood and Buccal Swab DNA
- 4 February 2017
- journal article
- research article
- Published by Springer Nature in Molecular Diagnosis & Therapy
- Vol. 21 (2) , 217-223
Abstract
Detection of pathogenic variants in hereditary breast and ovarian cancer-related breast cancer type 1 and type 2 susceptibility proteins (BRCA1/2) genes is an effective strategy in cancer prevention and treatment. Some ethnic and geographical regions show different BRCA1/2 mutation spectrum and prevalence. In Italy, elucidation of founder effect in BRCA1/2 genes can have an impact on the management of hereditary cancer families on a healthcare system level, making genetic testing more affordable and cost effective in certain regions. The purpose of this paper is to develop a rapid, low-cost, high-throughput single-tube technology for genotyping the Italian founder mutation c.4964_4982del19 (rs80359876) in the BRCA1 gene, starting from peripheral blood and/or buccal swab DNA. Heterozygote samples for c.4964_4982del19 variant were easily and unambiguously identified by the altered shape of the melting curves and were clearly distinguished by a change in melting temperature that differed by approximately 5 °C. The same results were obtained both with DNA from peripheral blood than buccal swab. We provide evidence about application of high-resolution melting analysis (HRMA) in unambiguously genotyping of the founder BRCA1 c.4964_4982del19 variant (rs80359876) in individuals from the Calabria region of Italy. In fact, HRMA was confirmed to be particularly suitable for the identification of BRCA1 c.4964_4982del19 variant, making this approach useful in clinical molecular diagnostics.Keywords
This publication has 23 references indexed in Scilit:
- Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature ReviewThe Oncologist, 2016
- The missing indels: an estimate of indel variation in a human genome and analysis of factors that impede detectionNucleic Acids Research, 2015
- DNA from buccal swab is suitable for rapid genotyping of angiotensin-converting enzyme insertion/deletion (I/D) polymorphismClinica Chimica Acta, 2014
- High-resolution melting: Applications in genetic disordersClinica Chimica Acta, 2012
- Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and controlEPMA Journal, 2010
- Amplicon Melting Analysis with Labeled Primers: A Closed-Tube Method for Differentiating Homozygotes and HeterozygotesClinical Chemistry, 2003
- BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counselingAnnals of Oncology, 2002
- Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancerHuman Mutation, 2001
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesThe American Journal of Human Genetics, 1998
- BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations.1996